We have located links that may give you full text access.
Intravitreal injection of triamcinolone acetonide for serous macular detachment in a patient with systemic lupus erythematosus.
PURPOSE: To report our experience with intravitreal triamcinolone acetonide treatment of serous macular detachment in a patient with active systemic lupus erythematosus (SLE).
METHODS: Interventional case report.
RESULTS: A 38-year-old man who had SLE with bilateral serous macular detachment and retinopathy was treated with a single intravitreal injection of triamcinolone acetonide in one eye and two intravenous injections of a megadose steroid. Serous detachment in the eye injected with intravitreal steroid showed more significant improvement than that in the fellow eye.
CONCLUSION: Our case suggests that intravitreal triamcinolone acetonide injection may be considered for treatment of SLE-related serous macular detachment that does not respond to systemic steroid therapy.
METHODS: Interventional case report.
RESULTS: A 38-year-old man who had SLE with bilateral serous macular detachment and retinopathy was treated with a single intravitreal injection of triamcinolone acetonide in one eye and two intravenous injections of a megadose steroid. Serous detachment in the eye injected with intravitreal steroid showed more significant improvement than that in the fellow eye.
CONCLUSION: Our case suggests that intravitreal triamcinolone acetonide injection may be considered for treatment of SLE-related serous macular detachment that does not respond to systemic steroid therapy.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices 
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app